BackShenzhen Kangtai Biological Products , Ltd. Overview

Shenzhen Kangtai Biological Products , Ltd. Receivables

Latest receivables for 300601.SZ: $2.7B.

Get informed when a big investor buys or sells

+ Follow
Receivables
$2.66B
↓ 6.13% YoYΔ $-173.64M vs prior year quarter

Peer trimmed avg / median

Loading

Shenzhen Kangtai Biological Products , Ltd. Receivables History

Loading

Shenzhen Kangtai Biological Products , Ltd. vs. peers: Receivables Comparison

Loading

Shenzhen Kangtai Biological Products , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Shenzhen Kangtai Biological Products , Ltd. (300601.SZ) FAQ

The latest receivables for 300601.SZ is $2.7B as of September 2026. That compares with $2.8B in the prior-year period — down 6.1% year over year. Investors often review this figure alongside Shenzhen Kangtai Biological Products , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 300601.SZ's receivables moved from $2.8B to $2.7B — a 6.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Shenzhen Kangtai Biological Products , Ltd.'s operating scale or balance-sheet position.

A receivables figure of $2.7B for 300601.SZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 300601.SZ's receivables ($2.7B), review year-over-year change from $2.8B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.